First Results of a Prospective Study on Erythropoietin Biosimilar (Epoetin zeta) Use in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
Mauricette Michallet(Université Claude Bernard Lyon 1), Franck E. Nicolini(Hôpital Lyon Sud), Fiorenza Barraco(Hôpital Lyon Sud), Xavier Thomas(Hôpital Lyon Sud), Mohamad Sobh(Ottawa Hospital), Sophie Ducastelle-Leprêtre(Hospices Civils de Lyon), Caroline Lejeune(Hôpital Lyon Sud), Marie Balsat(Hôpital Claude Huriez), Hélène Labussière‐Wallet, Jérémy Monfray(Hôpital Lyon Sud)
Cited by 0
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547